Saturday, December 9, 2023
Home Tags TNTY

Tag: TNTY

Mitesco
Research

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165%...

Editor / Curator -
Mitesco Inc,. Biotech Stock Review
All News

Biotech Stock Review: Mitesco (MITI) $0.03, Report Update

Editor / Curator -
Telehealth

True Nature | Mitesco (MITI) Raising $15 Million.

Editor / Curator -
Superbug News - CoronaVirus Watch List

Telehealth DTC Startup Ro is now Offering Coronavirus Assessments (ModernRetail).

Editor / Curator -
Biotech News

Our Favorite Incubator, Incubates! Telehealth in its Future?

Editor / Curator -
All News

Citius Pharma (CTXR), Fortress Biotech (FBIO) and True Nature (TNTY) Significantly...

Editor / Curator -
Biotech News

True Nature|Mitesco (TNTY). Coverage Report Issued.

Editor / Curator -
Biotech News

Mass General Brigham to Invest $100 Million in Telehealth and Digital...

Editor / Curator -
Mitesco, Biotech Stock Review
Incubator

True Nature (TNTY), a Medtech Startup Incubator Pays Down Some Toxic...

Editor / Curator -
True Nature, Mitesco, Biotech Stock Review
Incubator

Is True Nature (TNTY) $0.04, Nearing a Breakout?

Editor / Curator -
12Page 1 of 2

Latest article

Hundreds of Stocks Have Fallen Below $1. They’re Still Listed on Nasdaq. (WSJ)

Stand Down Editor / Curator -
Investor-protection advocates say many belong to risky small companies that should be on the OTC market. With 557 names...

Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.

All News Editor / Curator -
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.

LQR House (LQR). And the Numbers are In!

All News Editor / Curator -
A Situation Which Can't be Ignored! That's not to say run out and buy it, but this current valuation...
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.